Schmidt Syndrome

Schmidt Syndrome
Outside Resources
Radiopaedia	https://radiopaedia.org/articles/jugular-foramen-syndrome

Overview

Vagoaccessory syndrome (historically called "Schmidt syndrome" in neurological contexts) is a cranial nerve syndrome characterized by combined paralysis of cranial nerve X (vagus) and cranial nerve XI (accessory), with sparing of CN IX (glossopharyngeal). The syndrome results in ipsilateral paralysis of the soft palate, pharynx, and larynx (vagus) along with weakness of the sternocleidomastoid and trapezius muscles (accessory nerve).

Distinction from Vernet Syndrome

The key distinction of vagoaccessory syndrome from the more commonly described Vernet syndrome (jugular foramen syndrome) is the sparing of CN IX (glossopharyngeal):

Vagoaccessory Syndrome vs Vernet Syndrome

Feature	Vagoaccessory (Schmidt)	Vernet Syndrome
CN IX	Spared	Affected
CN X	Affected	Affected
CN XI	Affected	Affected
Frequency	Rare	More common
Anatomical basis	Selective brainstem or extracranial lesion	Jugular foramen lesion (all nerves affected)

Anatomical paradox: Since CN IX, X, and XI all traverse the jugular foramen, isolated X-XI involvement with sparing of CN IX is anatomically unusual for jugular foramen pathology. This isolated pattern is more likely to occur with:

• Lesions of the nucleus ambiguus (brainstem), which provides motor fibers for CN X and the cranial portion of CN XI but not the sensory components of CN IX
• Selective extracranial lesions affecting X and XI after they diverge from IX
• Idiopathic cranial polyneuropathy with selective nerve involvement

Vagoaccessory syndrome is caused by lesions affecting the nucleus ambiguus (which gives rise to motor fibers for both CN X and the cranial portion of CN XI) or affecting both nerves along their course after separation from CN IX. Causes include brainstem lesions (stroke, demyelination, tumor) and selective Skull base pathology.

History

The neurological "Schmidt syndrome" is attributed to Adolf Schmidt (1865–1918), a German physician who reportedly described the combination of vagus and accessory nerve paralysis, potentially in 1892. However, this historical claim requires verification, as contemporary literature searches do not readily confirm this specific attribution.

The medulla contains a concentration of cranial nerve nuclei in a small area, making it susceptible to producing distinct clinical syndromes when affected by focal lesions. The late 19th and early 20th centuries saw extensive efforts to map specific brainstem syndromes to anatomical locations, including:

• Wallenberg syndrome (1895): Lateral medullary infarction
• Vernet syndrome (1918): Jugular foramen syndrome (CN IX-X-XI)
• Collet-Sicard syndrome (1915/1917): CN IX-X-XI-XII

The isolated combination of CN X and XI palsy (vagoaccessory syndrome) is less commonly described than Vernet syndrome in both historical and contemporary literature, likely because most jugular foramen lesions affect CN IX along with X and XI.

Pathophysiology

Relevant Anatomy

Anatomical basis for combined CN X and XI involvement:

Nucleus ambiguus:

• Located in the ventrolateral medulla
• Motor nucleus for CN IX, X, and cranial portion of XI
• Provides efferent fibers for:
  • Pharyngeal muscles (CN X)
  • Laryngeal muscles (CN X via Recurrent laryngeal nerve)
  • Template:Nobr (CN X)
  • Upper esophagus (CN X)
• Cranial root of XI arises from nucleus ambiguus and joins vagus

Spinal accessory nucleus:

• Located in Cervical spinal cord (C1–C5)
• Gives rise to spinal root of CN XI
• Motor to sternocleidomastoid and trapezius

Course of cranial nerves X and XI:

Vagus nerve (X):

• Exits medulla from postolivary sulcus
• Traverses Jugular foramen
• Multiple branches providing motor, sensory, and parasympathetic innervation

Accessory nerve (XI):

• Cranial root: From nucleus ambiguus; joins vagus to supply laryngeal muscles
• Spinal root: From cervical spinal cord; provides motor to Template:Nobr and trapezius
• Both roots exit skull through jugular foramen
• Spinal root continues to muscles; cranial root joins vagus

Location of combined lesions:

Lesions causing Schmidt syndrome may occur at:

1. Nucleus ambiguus: Medullary lesion affecting both nuclei
2. Intracranial course: Near jugular foramen
3. Jugular foramen: Where CN X and XI pass together
4. Extracranial course: After exiting jugular foramen

Disease Etiology

Brainstem lesions (most likely to produce isolated X-XI involvement):

Brainstem lesions affecting the nucleus ambiguus are the most likely etiology for true isolated X-XI palsy with IX sparing, since the nucleus ambiguus provides motor output for X and the cranial root of XI, while CN IX has separate sensory nuclei.

• Lateral medullary infarction (Wallenberg syndrome variant)
• Medial medullary infarction (Dejerine syndrome variant)
• Brainstem hemorrhage
• Demyelinating disease (multiple sclerosis)
• Brainstem tumor (glioma, metastasis)
• Syringobulbia

Skull base lesions:

Most jugular foramen tumors produce Vernet syndrome (CN IX-X-XI) rather than isolated X-XI involvement. Selective X-XI involvement may occur with:

• Jugular foramen tumors with selective nerve involvement (paraganglioma, schwannoma, meningioma)
• Skull base metastases
• Nasopharyngeal carcinoma with skull base extension
• Chordoma, chondrosarcoma
• Developmental abnormalities of the craniocervical junction
• Cervical osteophytes compressing jugular foramen

Trauma:

• Skull base fractures involving jugular foramen
• Penetrating trauma
• Iatrogenic (surgery, particularly neck dissection)

Vascular:

• Vertebral artery dissection or aneurysm
• Internal jugular vein thrombosis—well-documented cause of jugular foramen syndromes
• Internal jugular vein phlebectasia

Infectious/Inflammatory:

• Varicella zoster virus (VZV)—documented cause of Vernet syndrome
• Skull base osteomyelitis
• Meningitis (particularly at skull base)
• Sarcoidosis

Idiopathic:

• Idiopathic cranial polyneuropathy—may present with selective lower cranial nerve involvement; pediatric cases may recover completely with corticosteroids

Diagnosis

Patient History

Symptoms reflect CN X and XI dysfunction:

Vagus nerve (X) symptoms:

• Dysphagia: Difficulty swallowing, particularly liquids
• Dysphonia: Hoarse, breathy voice
• Nasal regurgitation: Liquids coming out of nose
• Aspiration: Coughing with eating/drinking
• Reduced cough: Weak cough reflex

Accessory nerve (XI) symptoms:

• Shoulder droop: Weakness of trapezius
• Difficulty elevating arm: Above horizontal plane
• Weakness turning head: To contralateral side (Template:Nobr weakness)
• Neck/shoulder pain: From muscle weakness

Associated symptoms depend on etiology:

• Headache (vascular, tumor)
• Facial numbness (if CN V involved)
• Hearing loss, Vertigo (if CN VIII involved)
• Ataxia (cerebellar involvement)

Physical Examination

Cranial nerve X examination:

• Palate: Ipsilateral droop, Uvula deviates to contralateral side
• Gag reflex: Diminished on affected side (efferent limb)
• Voice: Hoarse, breathy quality
• Laryngoscopy: Ipsilateral vocal fold paralysis, pooling of secretions

Accessory nerve (XI) examination:

• Sternocleidomastoid: Weakness turning head to opposite side
• Trapezius: Shoulder droop, scapular winging, weakness of shoulder shrug
• Atrophy: May be present in chronic cases

Additional neurological examination:

• Assess other cranial nerves (IX, XII) to differentiate from related syndromes
• Cerebellar function
• Motor/sensory function (for brainstem involvement)
• Horner syndrome (sympathetic involvement)

Laboratory Tests

Guided by suspected etiology:

• CBC, inflammatory markers: Infection, Inflammation
• Coagulation studies: If vascular cause suspected
• ESR, CRP, ANA, ANCA: Autoimmune/inflammatory
• Lumbar puncture: If Meningitis, demyelinating disease, or Carcinomatous meningitis suspected

Imaging

Magnetic resonance imaging brain and skull base (with contrast):

• Imaging modality of choice
• Evaluate for:
  • Brainstem infarction
  • Demyelinating lesions
  • Mass lesions (brainstem, skull base)
  • Skull base pathology

MRA or CTA:

• Vertebral artery dissection
• Aneurysm
• Vascular malformation

CT skull base:

• Bony erosion
• Fractures
• Jugular foramen expansion (Tumor)

Differential Diagnosis

Related cranial nerve syndromes:

• Vernet syndrome (Jugular foramen syndrome): CN IX, X, XI
• Collet-Sicard syndrome: CN IX, X, XI, XII
• Jackson syndrome: CN X, XI, XII (medullary)
• Villaret syndrome: CN IX, X, XI, XII + Horner (retroparotid)
• Tapia syndrome: CN X, XII (Extracranial)

Other conditions:

• Isolated vagal neuropathy
• Isolated accessory neuropathy
• Motor neuron disease (progressive bulbar palsy)
• Myasthenia gravis

Management

Medical Management

Treatment depends on underlying etiology:

Vascular (stroke):

• Antiplatelet therapy, Statin
• Blood pressure management
• Stroke rehabilitation

Demyelinating disease:

• Corticosteroids for acute exacerbation
• Disease-modifying therapy

Infection:

• Appropriate antimicrobial therapy

Tumor:

• Oncologic treatment as appropriate

Supportive care:

• Dysphagia management:
  • Speech-language pathology evaluation
  • Modified diet textures
  • Swallowing therapy
  • Feeding tube if severe aspiration
• Voice therapy: For dysphonia
• Physical therapy: For shoulder weakness

Surgical Management

Depends on etiology:

Tumor resection:

• Skull base approaches for accessible tumors
• May require Multidisciplinary approach to care

Vocal fold medialization:

• For persistent Vocal fold paralysis
• Injection laryngoplasty (temporary or permanent)
• Thyroplasty (permanent)

Pharyngeal surgery:

• Rarely indicated
• Palatal adhesion or Pharyngoplasty for severe Velopharyngeal insufficiency

Outcomes

Complications

• Aspiration pneumonia: Major concern with CN X dysfunction
• Malnutrition/Dehydration: From Dysphagia
• Voice disability: Social and occupational impact
• Shoulder dysfunction: Reduced arm mobility
• Progression: May occur depending on underlying cause

Prognosis

Varies by etiology:

Vascular (stroke):

• Some recovery may occur over 6–12 months
• Degree of recovery depends on lesion extent
• Aspiration risk may persist

Tumor:

• Depends on Tumor type, resectability, stage

Demyelinating disease:

• May recover with treatment
• Risk of relapse

General considerations:

• Early Diagnosis and treatment improve outcomes
• Swallowing therapy can reduce Aspiration risk
• Voice therapy and procedures can improve Phonation
• Multidisciplinary approach is essential